Wall Street analyst estimates for Quaker Houghton (KWR): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Quaker Chemical Corporation is a global provider of specialized chemical formulations, which it develops, produces, and markets for a broad spectrum of heavy industrial and manufacturing applications. Its global operations are strategically divided into four segments: the Americas; Europe, the Middle East, and Africa (EMEA); Asia/Pacific; and dedicated Global Specialty Businesses.
Consensus price target
$186.33 (+23 % vs price $150.95)
between $172.00 and $202.00 · 3 targets published in the last quarter
Closing price, Oct 30
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $2.0B | $2.0B – $2.1B | $7.88 | 5 |
| 2027E | $2.1B | $2.1B – $2.1B | $9.49 | 5 |
Figures in USD · consensus as of November 1, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 9 |
| Hold | 7 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 16 |
| Avg rating (−2 sell to +2 buy) | 0.56 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2027-02-22 | $1.83 | ||
| 2026-10-29 | $2.39 | $2.10 | +13.8% |
| 2026-07-30 | $2.19 | $1.66 | +31.9% |
| 2026-04-30 | $1.63 | $1.66 | -1.8% |
| 2026-02-23 | $1.65 | $1.71 | -3.5% |
| 2025-10-30 | $2.08 | $1.94 | +7.2% |
| 2025-07-31 | $1.71 | $1.82 | -6.0% |
| 2025-05-01 | $1.58 | $1.52 | +3.9% |
Valuation Ratios
| P/E Ratio | 26.96 |
| Price / Book | 1.84 |
| Dividend Yield | 1.36% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $746.7M | $820.1M | $867.5M | $1.13B | $1.42B | $1.76B | $1.94B | $1.95B | $1.84B | $1.89B |
| Cost of Revenue | $467.1M | $528.6M | $555.2M | $741.4M | $904.2M | $1.17B | $1.33B | $1.25B | $1.15B | $1.21B |
| Gross Profit | $279.6M | $291.5M | $312.3M | $392.1M | $513.4M | $594.6M | $612.7M | $705.6M | $686.0M | $679.4M |
| Research & Development | $22.5M | $23.9M | $24.5M | 0 | 0 | 0 | 0 | $50.3M | 0 | 0 |
| Selling, General & Admin | $197.0M | $198.8M | $207.9M | $283.8M | $380.8M | $418.9M | $464.2M | $483.6M | $484.8M | $502.4M |
| Operating Expenses | $197.0M | $198.8M | $207.9M | $346.0M | $454.1M | $444.2M | $560.4M | $491.1M | $491.3M | $502.4M |
| Operating Income | $83.1M | $62.7M | $87.8M | $46.1M | $59.4M | $150.5M | $52.3M | $214.5M | $194.7M | $177.0M |
| EBITDA | $103.7M | $108.7M | $121.9M | $90.8M | $137.0M | $255.9M | $120.2M | $285.8M | $280.2M | $144.5M |
| Interest Expense | $2.9M | $3.9M | $6.2M | $17.0M | $26.6M | $22.3M | $32.6M | $50.7M | $45.8M | $44.0M |
| Pre-tax Income | $84.0M | $60.7M | $83.1M | $28.9M | $34.5M | $156.4M | $9.1M | $168.5M | $166.0M | $22.2M |
| Income Tax | $23.2M | $41.7M | $25.1M | $2.1M | -$5.3M | $34.9M | $24.9M | $55.6M | $49.3M | $24.6M |
| Net Income | $61.4M | $20.3M | $59.5M | $31.6M | $39.7M | $121.4M | -$15.9M | $112.7M | $116.6M | -$2.5M |
| EPS | $4.64 | $1.53 | $4.48 | $2.09 | $2.23 | $6.79 | -$0.89 | $6.27 | $6.51 | -$0.14 |
| EPS (Diluted) | $4.63 | $1.52 | $4.47 | $2.09 | $2.22 | $6.77 | -$0.89 | $6.26 | $6.51 | -$0.14 |
| Shares Outstanding (Diluted) | 13.2 M | 13.2 M | 13.3 M | 15.2 M | 17.8 M | 17.9 M | 17.9 M | 17.9 M | 17.8 M | 17.5 M |
Price
| Price | $150.95 (closing price, October 30, 2026) |
| Market Cap | $2.6B |
| Exchange | NYSE |
| Country | US |
Related companies: MEOH · HWKN · WDFC · IOSP · CSTM · CC · OLN · NGVT
Explore sector: Basic Materials · Chemicals - Specialty
More sections of KWR: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks